Evidence Synthesis
GEMAROMA has seen its 24.65% gross margin accelerate to 40.31% from 6.07% in the latest quarterly update.
This marks a significant improvement in the company's profitability.
By paying you agree to our Terms and Privacy Policy.
Evidence Synthesis
Last synthesized: 8 Jul 2026, 14:51
Evidence Synthesis
GEMAROMA has seen its 24.65% gross margin accelerate to 40.31% from 6.07% in the latest quarterly update.
This marks a significant improvement in the company's profitability.
Source observations behind the synthesis narrative.
| Metric | Value | Previous Value | Trend |
|---|---|---|---|
| GROSS_MARGIN | 24.65 % | 6.07 | ▲ |
| MARGINAL_OPERATING_LEVERAGE | 6.07 % | 0.39 | ▲ |
| REVENUE_GROWTH_YOY | -45.4 % | -96.8 | ▲ |
| PRICE_CHANGE_PERCENT | 12.896 % | — | - |
| DAILY_VOLUME | 1,42,66,089 shares | 87,927 | ▲ |
| CLOSE_PRICE | 219.07 INR | 194.02 | ▲ |